Tuesday, July 21, 2026
🇺🇸 FDA

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics Europe Ltd

United Therapeutics Europe patent portfolio — 90 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
25
Drugs
509
Patents
90
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

United Therapeutics Europe patents

90 pharmaceutical patents indexed for United Therapeutics Europe. 5 expire within 24 months.

United Therapeutics Europe has 90 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 5 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

90 patents

Patent portfolio

Page 1 of 2

  1. US 12357599

    Prodrugs of treprostinil

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12173021

    Treprostinil prodrugs

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12173306

    Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorders

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12168071

    Treprostinil derivatives and their use in pharmaceutical compositions

    Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11826328

    Stable treprostinil prodrugs

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11826327

    Treatment for interstitial lung disease

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11744828

    Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11723887

    Process to prepare treprostinil, the active ingredient in Remodulin®

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11707434

    Method for preparing organic solvent-free lyophilized cyclophosphamide

    Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11672775

    Treprostinil prodrugs

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11634443

    Treprostinil prodrugs

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11578315

    Truncated guinea pig L-asparaginase variants and methods of use

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11571444

    Enhancement of MSC immunomodulatory properties by treprostinil

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11357782

    Treprostinil administration by inhalation

    Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11236035

    Salts of treprostinil

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11103528

    Slow release calcium composition

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11000502

    Antimicrobial compositions comprising copper-hydroxypyrone complexes

    Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10988778

    Codon-optimized reduced-size ATP7A cDNA and uses for treatment of copper transport disorders

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10933076

    Crocin-sorafenib combination therapy for liver cancer

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10888558

    Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

    Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10836721

    Thalidomide analogs and methods of use

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10772897

    Method for on-demand contraception

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10730835

    Thalidomide analogs and methods of use

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10716793

    Treprostinil administration by inhalation

    Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10695308

    Inhalation formulations of treprostinil

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10568873

    Safranal-sorafenib combination therapy for liver cancer

    Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10548863

    Process to prepare treprostinil, the active ingredient in Remodulin®

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10478410

    Process to prepare treprostinil, the active ingredient in Remodulin®

    Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10376525

    Treprostinil administration by inhalation

    Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10342791

    Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

    Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10322099

    Process to prepare treprostinil, the active ingredient in remodulin®

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10182994

    Nanoparticulate complex of nicotine and cerium oxide and use thereof

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10172911

    Methods of modulating erythropoiesis with arginine vasopressin receptor 1B molecules

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10167247

    Solid forms of treprostinil

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10159681

    Method for on-demand contraception

    Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10076505

    Inhalation formulations of Treprostinil

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9988334

    Salts of treprostinil

    Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9822057

    Solid forms of treprostinil

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9713599

    Parenteral formulations of treprostinil

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9701611

    Salts of treprostinil

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9604901

    Process to prepare treprostinil, the active ingredient in Remodulin®

    Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9592207

    Intranasal administration of ketamine to treat depression

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9593066

    Process to prepare treprostinil, the active ingredient in remodulin®

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9534007

    Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity

    Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9464035

    Salicylic acid derivatives useful as glucocerebrosidase activators

    Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9358240

    Treprostinil administration by inhalation

    Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9339507

    Treprostinil administration by inhalation

    Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9283233

    Method for on-demand contraception

    Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

90 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

5 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.